Similarly, analysis of the TCGA datasets revealed that a subset of GBM patients with high FoxM1 mRNA expression (high 10%, n = 46) showed poor overall survival than the patients with low FoxM1 (low 10%, n = 46), although it was not statistically significant (S3B and S3C Fig, p-value = 0.086). The gene discussed is FOXM1; the disease is glioblastoma.